nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP2A6—Progesterone—uterine cancer	0.125	0.131	CbGbCtD
Cisapride—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0927	0.0972	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0852	0.0893	CbGbCtD
Cisapride—CYP3A7—Progesterone—uterine cancer	0.0852	0.0893	CbGbCtD
Cisapride—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0647	0.0678	CbGbCtD
Cisapride—CYP3A5—Progesterone—uterine cancer	0.0639	0.067	CbGbCtD
Cisapride—CYP2C8—Progesterone—uterine cancer	0.0614	0.0644	CbGbCtD
Cisapride—CYP2C19—Progesterone—uterine cancer	0.0515	0.054	CbGbCtD
Cisapride—CYP1A2—Progesterone—uterine cancer	0.0475	0.0498	CbGbCtD
Cisapride—CYP2C9—Progesterone—uterine cancer	0.0428	0.0449	CbGbCtD
Cisapride—CYP2D6—Progesterone—uterine cancer	0.0392	0.0411	CbGbCtD
Cisapride—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0376	0.0394	CbGbCtD
Cisapride—CYP3A5—Etoposide—uterine cancer	0.0286	0.03	CbGbCtD
Cisapride—CYP2C8—Etoposide—uterine cancer	0.0275	0.0288	CbGbCtD
Cisapride—CYP3A4—Progesterone—uterine cancer	0.0249	0.0261	CbGbCtD
Cisapride—CYP2B6—Doxorubicin—uterine cancer	0.0248	0.0259	CbGbCtD
Cisapride—CYP1A2—Etoposide—uterine cancer	0.0213	0.0223	CbGbCtD
Cisapride—CYP2D6—Doxorubicin—uterine cancer	0.012	0.0125	CbGbCtD
Cisapride—CYP3A4—Etoposide—uterine cancer	0.0111	0.0117	CbGbCtD
Cisapride—CYP3A4—Doxorubicin—uterine cancer	0.0076	0.00797	CbGbCtD
Cisapride—HTR2A—artery—uterine cancer	0.000834	0.049	CbGeAlD
Cisapride—HTR2B—myometrium—uterine cancer	0.000754	0.0443	CbGeAlD
Cisapride—KCNH2—myometrium—uterine cancer	0.000602	0.0354	CbGeAlD
Cisapride—HTR2B—uterine cervix—uterine cancer	0.000587	0.0345	CbGeAlD
Cisapride—HTR2B—smooth muscle tissue—uterine cancer	0.00057	0.0335	CbGeAlD
Cisapride—HTR2B—decidua—uterine cancer	0.000559	0.0329	CbGeAlD
Cisapride—HTR2B—endometrium—uterine cancer	0.000531	0.0312	CbGeAlD
Cisapride—CYP2A6—vagina—uterine cancer	0.000517	0.0304	CbGeAlD
Cisapride—HTR2B—uterus—uterine cancer	0.000489	0.0287	CbGeAlD
Cisapride—KCNH2—uterine cervix—uterine cancer	0.000468	0.0275	CbGeAlD
Cisapride—HTR2C—female reproductive system—uterine cancer	0.000468	0.0275	CbGeAlD
Cisapride—HTR2B—female reproductive system—uterine cancer	0.00044	0.0258	CbGeAlD
Cisapride—KCNH2—renal system—uterine cancer	0.000438	0.0257	CbGeAlD
Cisapride—KCNH2—endometrium—uterine cancer	0.000423	0.0249	CbGeAlD
Cisapride—CYP2C8—renal system—uterine cancer	0.000401	0.0235	CbGeAlD
Cisapride—HTR2B—vagina—uterine cancer	0.000398	0.0234	CbGeAlD
Cisapride—KCNH2—uterus—uterine cancer	0.00039	0.0229	CbGeAlD
Cisapride—CYP2C8—endometrium—uterine cancer	0.000387	0.0228	CbGeAlD
Cisapride—CYP3A5—uterine cervix—uterine cancer	0.000387	0.0227	CbGeAlD
Cisapride—CYP1A2—renal system—uterine cancer	0.000375	0.022	CbGeAlD
Cisapride—CYP3A5—renal system—uterine cancer	0.000362	0.0213	CbGeAlD
Cisapride—CYP2B6—renal system—uterine cancer	0.000359	0.0211	CbGeAlD
Cisapride—KCNH2—female reproductive system—uterine cancer	0.000351	0.0206	CbGeAlD
Cisapride—CYP2C19—vagina—uterine cancer	0.000333	0.0195	CbGeAlD
Cisapride—CYP2C8—female reproductive system—uterine cancer	0.000321	0.0189	CbGeAlD
Cisapride—KCNH2—female gonad—uterine cancer	0.000319	0.0188	CbGeAlD
Cisapride—KCNH2—vagina—uterine cancer	0.000317	0.0186	CbGeAlD
Cisapride—HTR2A—epithelium—uterine cancer	0.000316	0.0186	CbGeAlD
Cisapride—HTR2A—smooth muscle tissue—uterine cancer	0.000305	0.0179	CbGeAlD
Cisapride—HTR2A—renal system—uterine cancer	0.000293	0.0172	CbGeAlD
Cisapride—CYP2C8—vagina—uterine cancer	0.00029	0.0171	CbGeAlD
Cisapride—CYP2B6—female reproductive system—uterine cancer	0.000288	0.0169	CbGeAlD
Cisapride—CYP2C9—female reproductive system—uterine cancer	0.000285	0.0168	CbGeAlD
Cisapride—CYP3A4—renal system—uterine cancer	0.000271	0.0159	CbGeAlD
Cisapride—CYP2D6—renal system—uterine cancer	0.000267	0.0157	CbGeAlD
Cisapride—CYP3A5—female gonad—uterine cancer	0.000264	0.0155	CbGeAlD
Cisapride—CYP3A5—vagina—uterine cancer	0.000262	0.0154	CbGeAlD
Cisapride—CYP2B6—vagina—uterine cancer	0.00026	0.0153	CbGeAlD
Cisapride—HTR2B—lymph node—uterine cancer	0.000257	0.0151	CbGeAlD
Cisapride—HTR2A—female reproductive system—uterine cancer	0.000235	0.0138	CbGeAlD
Cisapride—CYP3A4—female reproductive system—uterine cancer	0.000217	0.0128	CbGeAlD
Cisapride—CYP2D6—female reproductive system—uterine cancer	0.000214	0.0126	CbGeAlD
Cisapride—HTR2A—vagina—uterine cancer	0.000212	0.0125	CbGeAlD
Cisapride—KCNH2—lymph node—uterine cancer	0.000205	0.0121	CbGeAlD
Cisapride—CYP2D6—female gonad—uterine cancer	0.000195	0.0114	CbGeAlD
Cisapride—DRD2—Signaling Pathways—AKR1C3—uterine cancer	1.26e-05	0.000434	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.24e-05	0.000428	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKR1C3—uterine cancer	1.24e-05	0.000427	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—RRM2—uterine cancer	1.24e-05	0.000427	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.23e-05	0.000426	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CDKN2B—uterine cancer	1.23e-05	0.000426	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PGR—uterine cancer	1.22e-05	0.000423	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.22e-05	0.000421	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—STK11—uterine cancer	1.22e-05	0.000421	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—POLD1—uterine cancer	1.22e-05	0.000421	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—POLD1—uterine cancer	1.21e-05	0.000417	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PGR—uterine cancer	1.21e-05	0.000416	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—DCN—uterine cancer	1.2e-05	0.000415	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IGF1R—uterine cancer	1.2e-05	0.000414	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—CXCL8—uterine cancer	1.19e-05	0.000412	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—YWHAE—uterine cancer	1.17e-05	0.000404	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—YWHAE—uterine cancer	1.15e-05	0.000397	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.14e-05	0.000394	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000391	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.13e-05	0.00039	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SMAD3—uterine cancer	1.13e-05	0.000389	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—KRAS—uterine cancer	1.12e-05	0.000389	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—FBXW7—uterine cancer	1.12e-05	0.000387	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STK11—uterine cancer	1.11e-05	0.000383	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—CCL2—uterine cancer	1.1e-05	0.000382	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—RRM2—uterine cancer	1.1e-05	0.000381	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—FBXW7—uterine cancer	1.1e-05	0.000381	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—CXCL8—uterine cancer	1.08e-05	0.000374	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—FGFR2—uterine cancer	1.07e-05	0.000371	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—DCN—uterine cancer	1.07e-05	0.00037	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.07e-05	0.000369	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SOCS3—uterine cancer	1.04e-05	0.000359	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—PIK3CA—uterine cancer	1.03e-05	0.000357	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—POLD1—uterine cancer	1.03e-05	0.000356	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—RRM2—uterine cancer	1.02e-05	0.000351	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—STAR—uterine cancer	1.01e-05	0.000351	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.01e-05	0.000351	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.01e-05	0.000349	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—RRM2—uterine cancer	1.01e-05	0.000348	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TP53—uterine cancer	1e-05	0.000345	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—MTHFR—uterine cancer	9.99e-06	0.000345	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN2B—uterine cancer	9.95e-06	0.000344	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—DCN—uterine cancer	9.85e-06	0.000341	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP19A1—uterine cancer	9.83e-06	0.00034	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—STK11—uterine cancer	9.83e-06	0.00034	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STK11—uterine cancer	9.79e-06	0.000338	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—DCN—uterine cancer	9.77e-06	0.000338	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—CCL2—uterine cancer	9.75e-06	0.000337	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IGF1R—uterine cancer	9.66e-06	0.000334	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKR1C1—uterine cancer	9.65e-06	0.000333	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STK11—uterine cancer	9.63e-06	0.000333	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—CXCL8—uterine cancer	9.61e-06	0.000332	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—STK11—uterine cancer	9.61e-06	0.000332	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP19A1—uterine cancer	9.61e-06	0.000332	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—CCL2—uterine cancer	9.59e-06	0.000331	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HRAS—uterine cancer	9.56e-06	0.00033	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKR1C3—uterine cancer	9.53e-06	0.000329	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP11A1—uterine cancer	9.28e-06	0.000321	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP11A1—uterine cancer	9.2e-06	0.000318	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ESR1—uterine cancer	9.18e-06	0.000317	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SOCS3—uterine cancer	9.17e-06	0.000317	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—MTHFR—uterine cancer	9.15e-06	0.000316	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SMAD3—uterine cancer	9.08e-06	0.000314	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SOCS3—uterine cancer	9.02e-06	0.000312	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN2B—uterine cancer	8.78e-06	0.000303	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKR1C3—uterine cancer	8.77e-06	0.000303	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—CXCL8—uterine cancer	8.73e-06	0.000302	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKR1C3—uterine cancer	8.69e-06	0.0003	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—NRAS—uterine cancer	8.68e-06	0.0003	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—FGFR2—uterine cancer	8.66e-06	0.000299	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN2B—uterine cancer	8.64e-06	0.000298	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—RRM2—uterine cancer	8.6e-06	0.000297	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IGF1R—uterine cancer	8.52e-06	0.000295	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—CXCL8—uterine cancer	8.49e-06	0.000293	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—AKT1—uterine cancer	8.44e-06	0.000292	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IGF1R—uterine cancer	8.39e-06	0.00029	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—CXCL8—uterine cancer	8.35e-06	0.000289	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—DCN—uterine cancer	8.35e-06	0.000288	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—STK11—uterine cancer	8.32e-06	0.000287	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP19A1—uterine cancer	8.32e-06	0.000287	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCL2—uterine cancer	8.09e-06	0.000279	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SMAD3—uterine cancer	8.01e-06	0.000277	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—POLD1—uterine cancer	7.96e-06	0.000275	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SMAD3—uterine cancer	7.89e-06	0.000272	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP11A1—uterine cancer	7.86e-06	0.000272	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.81e-06	0.00027	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—CXCL8—uterine cancer	7.71e-06	0.000266	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—FGFR2—uterine cancer	7.64e-06	0.000264	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—CXCL8—uterine cancer	7.58e-06	0.000262	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—PIK3CA—uterine cancer	7.56e-06	0.000261	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—FGFR2—uterine cancer	7.52e-06	0.00026	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—KRAS—uterine cancer	7.47e-06	0.000258	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.45e-06	0.000257	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKR1C1—uterine cancer	7.45e-06	0.000257	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKR1C3—uterine cancer	7.43e-06	0.000257	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP19A1—uterine cancer	7.43e-06	0.000257	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—STK11—uterine cancer	7.43e-06	0.000257	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ESR1—uterine cancer	7.41e-06	0.000256	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—MTHFR—uterine cancer	7.38e-06	0.000255	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—MTHFR—uterine cancer	7.22e-06	0.000249	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—NRAS—uterine cancer	7e-06	0.000242	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.97e-06	0.000241	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PIK3CA—uterine cancer	6.87e-06	0.000237	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—STK11—uterine cancer	6.83e-06	0.000236	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP19A1—uterine cancer	6.83e-06	0.000236	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP19A1—uterine cancer	6.77e-06	0.000234	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—STK11—uterine cancer	6.77e-06	0.000234	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—ERBB2—uterine cancer	6.74e-06	0.000233	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.65e-06	0.00023	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—RRM2—uterine cancer	6.64e-06	0.000229	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ESR1—uterine cancer	6.54e-06	0.000226	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCL2—uterine cancer	6.52e-06	0.000225	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—DCN—uterine cancer	6.44e-06	0.000223	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ESR1—uterine cancer	6.43e-06	0.000222	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CXCL8—uterine cancer	6.39e-06	0.000221	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.36e-06	0.00022	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HRAS—uterine cancer	6.35e-06	0.000219	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—MTHFR—uterine cancer	6.25e-06	0.000216	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CDKN1B—uterine cancer	6.24e-06	0.000216	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—NRAS—uterine cancer	6.18e-06	0.000214	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—AKT1—uterine cancer	6.18e-06	0.000213	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—PIK3CA—uterine cancer	6.1e-06	0.000211	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—NRAS—uterine cancer	6.08e-06	0.00021	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.07e-06	0.00021	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.06e-06	0.000209	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—KRAS—uterine cancer	6.03e-06	0.000208	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CTNNB1—uterine cancer	5.9e-06	0.000204	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—STK11—uterine cancer	5.79e-06	0.0002	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP19A1—uterine cancer	5.79e-06	0.0002	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCL2—uterine cancer	5.76e-06	0.000199	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PTEN—uterine cancer	5.75e-06	0.000199	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKR1C3—uterine cancer	5.73e-06	0.000198	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCL2—uterine cancer	5.66e-06	0.000196	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—uterine cancer	5.61e-06	0.000194	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MTHFR—uterine cancer	5.58e-06	0.000193	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTEN—uterine cancer	5.56e-06	0.000192	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PIK3CA—uterine cancer	5.54e-06	0.000191	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.51e-06	0.00019	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EP300—uterine cancer	5.48e-06	0.000189	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—ERBB2—uterine cancer	5.44e-06	0.000188	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.43e-06	0.000188	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	5.38e-06	0.000186	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—KRAS—uterine cancer	5.32e-06	0.000184	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—EP300—uterine cancer	5.3e-06	0.000183	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	5.3e-06	0.000183	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—KRAS—uterine cancer	5.24e-06	0.000181	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—uterine cancer	5.19e-06	0.000179	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.18e-06	0.000179	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CXCL8—uterine cancer	5.16e-06	0.000178	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MTHFR—uterine cancer	5.13e-06	0.000177	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NRAS—uterine cancer	5.13e-06	0.000177	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRAS—uterine cancer	5.12e-06	0.000177	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTEN—uterine cancer	5.09e-06	0.000176	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MTHFR—uterine cancer	5.09e-06	0.000176	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	5.04e-06	0.000174	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	4.98e-06	0.000172	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.92e-06	0.00017	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	4.89e-06	0.000169	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—EP300—uterine cancer	4.86e-06	0.000168	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	4.81e-06	0.000166	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—ERBB2—uterine cancer	4.8e-06	0.000166	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	4.76e-06	0.000164	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—ERBB2—uterine cancer	4.72e-06	0.000163	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PTEN—uterine cancer	4.64e-06	0.00016	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CXCL8—uterine cancer	4.55e-06	0.000157	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—uterine cancer	4.52e-06	0.000156	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRAS—uterine cancer	4.52e-06	0.000156	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.48e-06	0.000155	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CXCL8—uterine cancer	4.48e-06	0.000155	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.47e-06	0.000154	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—STK11—uterine cancer	4.47e-06	0.000154	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRAS—uterine cancer	4.45e-06	0.000154	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN1B—uterine cancer	4.45e-06	0.000154	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EP300—uterine cancer	4.42e-06	0.000153	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KRAS—uterine cancer	4.41e-06	0.000153	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—uterine cancer	4.4e-06	0.000152	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	4.37e-06	0.000151	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MTHFR—uterine cancer	4.35e-06	0.00015	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	4.33e-06	0.00015	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CTNNB1—uterine cancer	4.2e-06	0.000145	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—uterine cancer	4.19e-06	0.000145	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NRAS—uterine cancer	4.14e-06	0.000143	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	4.13e-06	0.000143	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTEN—uterine cancer	4.11e-06	0.000142	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PTEN—uterine cancer	4.09e-06	0.000141	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	4.06e-06	0.00014	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PTEN—uterine cancer	4.03e-06	0.000139	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTEN—uterine cancer	4.02e-06	0.000139	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—uterine cancer	3.99e-06	0.000138	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—uterine cancer	3.93e-06	0.000136	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—uterine cancer	3.92e-06	0.000136	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.92e-06	0.000135	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—EP300—uterine cancer	3.92e-06	0.000135	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EP300—uterine cancer	3.9e-06	0.000135	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EP300—uterine cancer	3.84e-06	0.000133	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.83e-06	0.000132	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—EP300—uterine cancer	3.83e-06	0.000132	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRAS—uterine cancer	3.75e-06	0.00013	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—uterine cancer	3.7e-06	0.000128	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NRAS—uterine cancer	3.65e-06	0.000126	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—uterine cancer	3.64e-06	0.000126	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NRAS—uterine cancer	3.59e-06	0.000124	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—uterine cancer	3.59e-06	0.000124	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KRAS—uterine cancer	3.56e-06	0.000123	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTEN—uterine cancer	3.48e-06	0.00012	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MTHFR—uterine cancer	3.36e-06	0.000116	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—EP300—uterine cancer	3.32e-06	0.000115	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—uterine cancer	3.31e-06	0.000114	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	3.27e-06	0.000113	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—uterine cancer	3.2e-06	0.000111	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—uterine cancer	3.17e-06	0.000109	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KRAS—uterine cancer	3.14e-06	0.000109	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTEN—uterine cancer	3.1e-06	0.000107	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KRAS—uterine cancer	3.09e-06	0.000107	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRAS—uterine cancer	3.03e-06	0.000105	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—EP300—uterine cancer	2.96e-06	0.000102	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—uterine cancer	2.93e-06	0.000101	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.9e-06	0.0001	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—uterine cancer	2.89e-06	9.98e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTEN—uterine cancer	2.86e-06	9.87e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	2.84e-06	9.82e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.83e-06	9.79e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTEN—uterine cancer	2.83e-06	9.78e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—uterine cancer	2.79e-06	9.65e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—uterine cancer	2.75e-06	9.5e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—EP300—uterine cancer	2.72e-06	9.41e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—EP300—uterine cancer	2.7e-06	9.33e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—uterine cancer	2.67e-06	9.24e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRAS—uterine cancer	2.67e-06	9.23e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRAS—uterine cancer	2.63e-06	9.08e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.45e-06	8.48e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTEN—uterine cancer	2.42e-06	8.36e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—uterine cancer	2.37e-06	8.18e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—uterine cancer	2.36e-06	8.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—uterine cancer	2.32e-06	8.02e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—uterine cancer	2.31e-06	8e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—EP300—uterine cancer	2.31e-06	7.97e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.19e-06	7.57e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.01e-06	6.96e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—uterine cancer	2e-06	6.93e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—uterine cancer	2e-06	6.9e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTEN—uterine cancer	1.87e-06	6.45e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—uterine cancer	1.79e-06	6.18e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—EP300—uterine cancer	1.78e-06	6.15e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.71e-06	5.9e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—uterine cancer	1.65e-06	5.69e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—uterine cancer	1.63e-06	5.64e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—uterine cancer	1.39e-06	4.82e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.32e-06	4.55e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—uterine cancer	1.08e-06	3.72e-05	CbGpPWpGaD
